Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019

Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019 provides an overview of Hemostasis Rapid Tests & Point of Care (POC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostasis Rapid Tests & Point of Care (POC) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hemostasis Rapid Tests & Point of Care (POC) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hemostasis Rapid Tests & Point of Care (POC) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hemostasis Rapid Tests & Point of Care (POC) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date


  • Introduction
    • Hemostasis Rapid Tests & Point of Care (POC) Overview
  • Products under Development
    • Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development
      • Table Figure 1: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development
      • Table Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development
    • Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Territory
      • Table Figure 2: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Territory
      • Table Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Territory
    • Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Regulatory Path
      • Table Figure 3: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Regulatory Path
      • Table Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Regulatory Path
    • Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Estimated Approval Date
      • Table Figure 4: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Estimated Approval Date
      • Table Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Estimated Approval Date
  • Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products under Development by Companies
    • Hemostasis Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development
      • Table Hemostasis Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development
    • Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development
      • Table Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development
  • Hemostasis Rapid Tests & Point of Care (POC) Companies and Product Overview
    • Atomo Diagnostics Pty Ltd Company Overview
      • Atomo Diagnostics Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview.
        • Table Atomo Diagnostics Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table AtomoRapid - Coagulation Monitoring - Product Status
        • Table AtomoRapid - Coagulation Monitoring - Product Description
    • Carclo Diagnostic Solutions Ltd Company Overview
      • Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Micropoc-CAT - Haemostasis Assay - Product Status
        • Table Micropoc-CAT - Haemostasis Assay - Product Description
    • Cascade Metrix LLC Company Overview
      • Cascade Metrix LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cascade Metrix LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Multiple Blood Analytes Test - Product Status
        • Table Multiple Blood Analytes Test - Product Description
    • Edan Instruments Inc Company Overview
      • Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table i15 - Coagulation Test - Product Status
        • Table i15 - Coagulation Test - Product Description
    • EKF Diagnostics Holdings Plc Company Overview
      • EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Point-Of-Care Test - Coagulation - Product Status
        • Table Point-Of-Care Test - Coagulation - Product Description
    • Emosis SAS Company Overview
      • Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table ClotSeek - Product Status
        • Table ClotSeek - Product Description
    • Fraunhofer Institute for Cell Therapy and Immunology Company Overview
      • Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Point-Of-Care Assay - Primary And Secondary Hemostasis - Product Status
        • Table Point-Of-Care Assay - Primary And Secondary Hemostasis - Product Description
    • Helena Laboratories Corp Company Overview
      • Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cascade Abrazo - Activated Partial Thromboplastin Time (aPTT) - Product Status
        • Table Cascade Abrazo - Activated Partial Thromboplastin Time (aPTT) - Product Description
        • Table Cascade Abrazo - c-ACT - Product Status
        • Table Cascade Abrazo - c-ACT - Product Description
        • Table Cascade Abrazo - c-ACT-LR - Product Status
        • Table Cascade Abrazo - c-ACT-LR - Product Description
        • Table Cascade Abrazo - Direct Oral Anticoagulants Test - Product Status
        • Table Cascade Abrazo - Direct Oral Anticoagulants Test - Product Description
        • Table Cascade Abrazo - Direct Thrombin Inhibitors - Product Status
        • Table Cascade Abrazo - Direct Thrombin Inhibitors - Product Description
        • Table Cascade Abrazo - Fibrinogen - Product Status
        • Table Cascade Abrazo - Fibrinogen - Product Description
        • Table Cascade Abrazo - Heparin Titration - Product Status
        • Table Cascade Abrazo - Heparin Titration - Product Description
        • Table Cascade Abrazo - LMWH - Product Status
        • Table Cascade Abrazo - LMWH - Product Description
        • Table Cascade Abrazo - Protamine Titration - Product Status
        • Table Cascade Abrazo - Protamine Titration - Product Description
    • Universal Biosensors Inc Company Overview
      • Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Coagulation - Product Status
        • Table Diagnostic Assay - Coagulation - Product Description
  • Hemostasis Rapid Tests & Point of Care (POC) - Recent Developments
    • Apr 08, 2019: Aggredyne receives FDA clearance for ADP platelet aggregation testing cartridge
    • Nov 22, 2018: EMOSIS reinforces its Intellectual Property and scientific expertise
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook